The Technical AnalystExchange: HEL Sector: Healthcare Industry: Medical Devices
BBS-Bioactive Bone Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.94% €0.472
America/New_York / 2 mai 2024 @ 10:57
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 10.01 mill |
| EPS: | -0.240 |
| P/E: | -1.970 |
| Earnings Date: | Aug 30, 2024 |
| SharesOutstanding: | 21.20 mill |
| Avg Daily Volume: | 0.0326 mill |
| RATING 2024-05-02 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.970 | sector: PE 13.91 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.05x |
| Company: PE -1.970 | industry: PE 40.39 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€-0.292 (-161.92%) €-0.764 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
€ 0.442 - 0.502 ( +/- 6.36%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €0.472 (1.94% ) |
| Volume | 0.0113 mill |
| Avg. Vol. | 0.0326 mill |
| % of Avg. Vol | 34.68 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BONEH.HE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BONEH.HE
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. The company offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. BBS-Bioactive Bone Substitutes Plc was incorporated in 1991 and is headquartered in Oulu, Finland.